Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
0 investors
0 investors
ClearNote Health develops DNA-based blood tests (the Avantect line for pancreatic, ovarian, and multi-cancer detection) aimed at detecting cancer at early stages in patients at elevated risk. It also offers Virtuoso, an epigenomics platform that measures disease biology and therapy response from a blood draw for drug discovery and development.
0 investors
Clene is a clinical-stage biopharmaceutical company developing nanotherapeutics that target cellular energy impairments to treat neurodegenerative diseases and restore neuronal health. Its platform produces clean-surfaced, catalytically-active nanocrystals for therapeutic use.
0 investors
0 investors
0 investors
0 investors
0 investors
CNS Pharmaceuticals is a biotechnology company developing therapies for neurological and oncological diseases with significant unmet medical needs. The company focuses on identifying and advancing differentiated therapeutic candidates to improve patient outcomes.
0 investors
Co-Dx develops real-time PCR diagnostic tests and a portable qPCR platform for use at home, in businesses, and at point-of-care facilities. Its testing solutions, powered by proprietary Co-Primers technology, target infectious diseases and are offered as in vitro diagnostic and research-use products.
0 investors
Coagulation Sciences develops testing solutions for patients with bleeding disorders. The company works with advisors specializing in medical devices, hematology, and coagulation research.
0 investors
Cocrystal Pharma is a clinical-stage biotechnology company that discovers and develops broad-spectrum antiviral drugs targeting the replication process of viruses including influenza, coronaviruses (SARS-CoV-2, MERS), norovirus, and hepatitis C. It uses structure-based drug discovery technologies to develop treatments for serious and chronic viral diseases such as influenza, COVID-19, hepatitis C, and norovirus-caused gastroenteritis.
0 investors
0 investors
0 investors
0 investors
CoFlo Medical develops a drug-delivery platform based on core annular flow, which surrounds a viscous drug with a thin low-viscosity fluid so ultra-high-concentration biologics can be injected through fine needles at low force. Its CO-AXL hub adapts any primary container to enable at-home injection of highly viscous formulations (up to 400 mg/mL and over 1,000 cP), serving pharmaceutical developers and patients.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors